Overview Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases Status: Completed Trial end date: 2008-02-01 Target enrollment: Participant gender: Summary Phase 1, Multiple dose Study of MPC-6827 in Subjects with Refractory Brain Metastases. Phase: Phase 1 Details Lead Sponsor: Myrexis Inc.